ATE237360T1 - Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation - Google Patents
Verbesserungen der oder in bezug auf die regulierung der t-zellaktivationInfo
- Publication number
- ATE237360T1 ATE237360T1 AT98940480T AT98940480T ATE237360T1 AT E237360 T1 ATE237360 T1 AT E237360T1 AT 98940480 T AT98940480 T AT 98940480T AT 98940480 T AT98940480 T AT 98940480T AT E237360 T1 ATE237360 T1 AT E237360T1
- Authority
- AT
- Austria
- Prior art keywords
- relating
- regulation
- cell activation
- subject
- cell
- Prior art date
Links
- 230000019908 regulation of T cell activation Effects 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9718872.6A GB9718872D0 (en) | 1997-09-06 | 1997-09-06 | Improvements in or relating to expression of immunogenic substances |
| GBGB9723448.8A GB9723448D0 (en) | 1997-09-06 | 1997-11-07 | Improvements in or relating to expression of immunogenic substances |
| US7644898P | 1998-03-02 | 1998-03-02 | |
| PCT/GB1998/002689 WO1999012573A1 (en) | 1997-09-06 | 1998-09-07 | Improvements in or relating to regulation of t cell activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE237360T1 true ATE237360T1 (de) | 2003-05-15 |
Family
ID=27269003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98940480T ATE237360T1 (de) | 1997-09-06 | 1998-09-07 | Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP1015036A1 (de) |
| JP (2) | JP2001515709A (de) |
| AT (1) | ATE237360T1 (de) |
| AU (2) | AU734877B2 (de) |
| CA (2) | CA2303618A1 (de) |
| DE (1) | DE69813573T2 (de) |
| WO (2) | WO1999012573A1 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589362A (en) * | 1993-06-14 | 1996-12-31 | Basf Aktiengesellschaft | Tetracycline regulated transcriptional modulators with altered DNA binding specificities |
-
1998
- 1998-09-07 AU AU88799/98A patent/AU734877B2/en not_active Ceased
- 1998-09-07 AU AU89926/98A patent/AU747045B2/en not_active Ceased
- 1998-09-07 JP JP2000510471A patent/JP2001515709A/ja not_active Withdrawn
- 1998-09-07 WO PCT/GB1998/002689 patent/WO1999012573A1/en active IP Right Grant
- 1998-09-07 EP EP98941611A patent/EP1015036A1/de not_active Withdrawn
- 1998-09-07 WO PCT/GB1998/002693 patent/WO1999012574A1/en not_active Application Discontinuation
- 1998-09-07 CA CA002303618A patent/CA2303618A1/en not_active Abandoned
- 1998-09-07 CA CA002303617A patent/CA2303617A1/en not_active Abandoned
- 1998-09-07 DE DE69813573T patent/DE69813573T2/de not_active Expired - Fee Related
- 1998-09-07 AT AT98940480T patent/ATE237360T1/de not_active IP Right Cessation
- 1998-09-07 EP EP98940480A patent/EP1009442B1/de not_active Expired - Lifetime
- 1998-09-07 JP JP2000510470A patent/JP2001515873A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE69813573D1 (de) | 2003-05-22 |
| JP2001515709A (ja) | 2001-09-25 |
| CA2303617A1 (en) | 1999-03-18 |
| AU747045B2 (en) | 2002-05-09 |
| AU734877B2 (en) | 2001-06-21 |
| EP1009442A1 (de) | 2000-06-21 |
| WO1999012574A1 (en) | 1999-03-18 |
| EP1015036A1 (de) | 2000-07-05 |
| WO1999012573A1 (en) | 1999-03-18 |
| JP2001515873A (ja) | 2001-09-25 |
| DE69813573T2 (de) | 2004-02-26 |
| EP1009442B1 (de) | 2003-04-16 |
| AU8992698A (en) | 1999-03-29 |
| CA2303618A1 (en) | 1999-03-18 |
| AU8879998A (en) | 1999-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL118201A0 (en) | Erythropoietin free of animal proteins processes for production and use thereof | |
| ES2153444T3 (es) | Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion. | |
| ATE319827T1 (de) | Polypeptid, das die differenzierung unterdrueckt | |
| DK0559884T3 (da) | Rekombinante virusvektorer til ekspression i muskelceller | |
| ES2046462T3 (es) | Marcadores de activacion de celulas "t". | |
| DE69334257D1 (de) | Methode zur Einführung von genetischem Material in Zellen | |
| ES2185695T3 (es) | Terapia genica dirigida. | |
| PL267473A1 (en) | A transskin curative system and a method of its production | |
| ATE127694T1 (de) | Lebende impfstoffe. | |
| ATE69241T1 (de) | Herstellung von polypeptiden mit humangammainterferon-aktivitaet. | |
| NO177270C (no) | Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren | |
| BR9712556A (pt) | Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno | |
| DK0572688T3 (da) | Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi | |
| ES2078243T3 (es) | Mejoras en o relativas a la expresion eucariotica. | |
| ATE237360T1 (de) | Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation | |
| NO873437D0 (no) | Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon. | |
| ES8605296A1 (es) | Procedimiento de producir factor viii-r humano | |
| ATE346863T1 (de) | Verwendung von eif4e-bindungsreagenzien in der therapie | |
| JPS6480298A (en) | Production of human proapolipoprotein a-i-like protein | |
| AR242636A1 (es) | Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos. | |
| IT1152720B (it) | La demarizzazione delle acque di vegetazione, il recupero dell'olivamarina e la produzione di concentrati e di farine deamarizzati naturali o fermentati, per alimentazione umana od animale | |
| BR9811531A (pt) | Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga | |
| ES8600651A1 (es) | Agente anti-tumoral | |
| RU97102947A (ru) | Способ лечения диффузного токсического зоба |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |